Horgan, A. M., Seruga, B., Pond, G. R., Alibhai, S. M., Amir, E., De Wit, R., . . . Tannock, I. F. (2014). Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial. J Geriatr Oncol.
Stile di citazione ChicagoHorgan, Anne M., Bostjan Seruga, Greg R. Pond, Shabbir M. Alibhai, Eitan Amir, Ronald De Wit, Mario A. Eisenberger, e Ian F. Tannock. "Tolerability and Efficacy of Docetaxel in Older Men With Metastatic Castrate-resistant Prostate Cancer (mCRPC) in the TAX 327 Trial." J Geriatr Oncol 2014.
Citazione MLAHorgan, Anne M., et al. "Tolerability and Efficacy of Docetaxel in Older Men With Metastatic Castrate-resistant Prostate Cancer (mCRPC) in the TAX 327 Trial." J Geriatr Oncol 2014.